Selected research
Industry Research
Recombinant Carbonyl Reductase Industry Research Report 2026
Market perspective
The global Recombinant Carbonyl Reductase market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Recombinant Carbonyl Reductase is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Recombinant Carbonyl Reductase is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Recombinant Carbonyl Reductase is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Recombinant Carbonyl Reductase include Abbexa, Abcam, American Research Products, Inc., Biocompare, Biomatik, Cosmo Bio USA, Fisher Scientific, Nordic Diagnostica AB and Novatein Biosciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Recombinant Carbonyl Reductase market in terms of revenue (US$ million) and, where applicable, sales volume (K G), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K G) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Recombinant Carbonyl Reductase Market by Company
Abbexa
Abcam
American Research Products, Inc.
Biocompare
Biomatik
Cosmo Bio USA
Fisher Scientific
Nordic Diagnostica AB
Novatein Biosciences
Prospec Bio
RayBiotech
Tebubio
Sino Biological
Cloud-Clone Corp
JUYOU
Recombinant Carbonyl Reductase Segment by Type
Liquid
Powder
Recombinant Carbonyl Reductase Segment by Application
Pharmaceutical Synthesis
Chemical Manufacturing
Others
Recombinant Carbonyl Reductase Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Carbonyl Reductase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Recombinant Carbonyl Reductase and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Carbonyl Reductase.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Recombinant Carbonyl Reductase manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Recombinant Carbonyl Reductase by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Recombinant Carbonyl Reductase in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Liquid
- Powder
Applications
- Pharmaceutical Synthesis
- Chemical Manufacturing
- Others
Companies covered
- Abbexa
- Abcam
- American Research Products, Inc.
- Biocompare
- Biomatik
- Cosmo Bio USA
- Fisher Scientific
- Nordic Diagnostica AB
- Novatein Biosciences
- Prospec Bio
- RayBiotech
- Tebubio
- Sino Biological
- Cloud-Clone Corp
- JUYOU
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Recombinant Carbonyl Reductase Market Size (2021-2032)
- 2.2.2 Global Recombinant Carbonyl Reductase Sales (2021-2032)
- 2.2.3 Global Recombinant Carbonyl Reductase Market Average Price (2021-2032)
- 2.3 Recombinant Carbonyl Reductase by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Liquid
- 2.3.3 Powder
- 2.4 Recombinant Carbonyl Reductase by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmaceutical Synthesis
- 2.4.3 Chemical Manufacturing
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Recombinant Carbonyl Reductase Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Recombinant Carbonyl Reductase Sales (K G) of Manufacturers (2021-2026)
- 3.3 Global Recombinant Carbonyl Reductase Revenue of Manufacturers (2021-2026)
- 3.4 Global Recombinant Carbonyl Reductase Average Price by Manufacturers (2021-2026)
- 3.5 Global Recombinant Carbonyl Reductase Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Recombinant Carbonyl Reductase, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Recombinant Carbonyl Reductase, Product Type & Application
- 3.8 Global Manufacturers of Recombinant Carbonyl Reductase, Established Date
- 3.9 Global Recombinant Carbonyl Reductase Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbexa
- 4.1.1 Abbexa Company Information
- 4.1.2 Abbexa Business Overview
- 4.1.3 Abbexa Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbexa Recombinant Carbonyl Reductase Product Portfolio
- 4.1.5 Abbexa Recent Developments
- 4.2 Abcam
- 4.2.1 Abcam Company Information
- 4.2.2 Abcam Business Overview
- 4.2.3 Abcam Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Abcam Recombinant Carbonyl Reductase Product Portfolio
- 4.2.5 Abcam Recent Developments
- 4.3 American Research Products, Inc.
- 4.3.1 American Research Products, Inc. Company Information
- 4.3.2 American Research Products, Inc. Business Overview
- 4.3.3 American Research Products, Inc. Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 American Research Products, Inc. Recombinant Carbonyl Reductase Product Portfolio
- 4.3.5 American Research Products, Inc. Recent Developments
- 4.4 Biocompare
- 4.4.1 Biocompare Company Information
- 4.4.2 Biocompare Business Overview
- 4.4.3 Biocompare Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Biocompare Recombinant Carbonyl Reductase Product Portfolio
- 4.4.5 Biocompare Recent Developments
- 4.5 Biomatik
- 4.5.1 Biomatik Company Information
- 4.5.2 Biomatik Business Overview
- 4.5.3 Biomatik Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Biomatik Recombinant Carbonyl Reductase Product Portfolio
- 4.5.5 Biomatik Recent Developments
- 4.6 Cosmo Bio USA
- 4.6.1 Cosmo Bio USA Company Information
- 4.6.2 Cosmo Bio USA Business Overview
- 4.6.3 Cosmo Bio USA Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Cosmo Bio USA Recombinant Carbonyl Reductase Product Portfolio
- 4.6.5 Cosmo Bio USA Recent Developments
- 4.7 Fisher Scientific
- 4.7.1 Fisher Scientific Company Information
- 4.7.2 Fisher Scientific Business Overview
- 4.7.3 Fisher Scientific Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Fisher Scientific Recombinant Carbonyl Reductase Product Portfolio
- 4.7.5 Fisher Scientific Recent Developments
- 4.8 Nordic Diagnostica AB
- 4.8.1 Nordic Diagnostica AB Company Information
- 4.8.2 Nordic Diagnostica AB Business Overview
- 4.8.3 Nordic Diagnostica AB Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Nordic Diagnostica AB Recombinant Carbonyl Reductase Product Portfolio
- 4.8.5 Nordic Diagnostica AB Recent Developments
- 4.9 Novatein Biosciences
- 4.9.1 Novatein Biosciences Company Information
- 4.9.2 Novatein Biosciences Business Overview
- 4.9.3 Novatein Biosciences Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Novatein Biosciences Recombinant Carbonyl Reductase Product Portfolio
- 4.9.5 Novatein Biosciences Recent Developments
- 4.10 Prospec Bio
- 4.10.1 Prospec Bio Company Information
- 4.10.2 Prospec Bio Business Overview
- 4.10.3 Prospec Bio Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Prospec Bio Recombinant Carbonyl Reductase Product Portfolio
- 4.10.5 Prospec Bio Recent Developments
- 4.11 RayBiotech
- 4.11.1 RayBiotech Company Information
- 4.11.2 RayBiotech Business Overview
- 4.11.3 RayBiotech Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 RayBiotech Recombinant Carbonyl Reductase Product Portfolio
- 4.11.5 RayBiotech Recent Developments
- 4.12 Tebubio
- 4.12.1 Tebubio Company Information
- 4.12.2 Tebubio Business Overview
- 4.12.3 Tebubio Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Tebubio Recombinant Carbonyl Reductase Product Portfolio
- 4.12.5 Tebubio Recent Developments
- 4.13 Sino Biological
- 4.13.1 Sino Biological Company Information
- 4.13.2 Sino Biological Business Overview
- 4.13.3 Sino Biological Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Sino Biological Recombinant Carbonyl Reductase Product Portfolio
- 4.13.5 Sino Biological Recent Developments
- 4.14 Cloud-Clone Corp
- 4.14.1 Cloud-Clone Corp Company Information
- 4.14.2 Cloud-Clone Corp Business Overview
- 4.14.3 Cloud-Clone Corp Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Cloud-Clone Corp Recombinant Carbonyl Reductase Product Portfolio
- 4.14.5 Cloud-Clone Corp Recent Developments
- 4.15 JUYOU
- 4.15.1 JUYOU Company Information
- 4.15.2 JUYOU Business Overview
- 4.15.3 JUYOU Recombinant Carbonyl Reductase Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 JUYOU Recombinant Carbonyl Reductase Product Portfolio
- 4.15.5 JUYOU Recent Developments
5 Global Recombinant Carbonyl Reductase Market Scenario by Region
- 5.1 Global Recombinant Carbonyl Reductase Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Recombinant Carbonyl Reductase Sales by Region: 2021-2032
- 5.2.1 Global Recombinant Carbonyl Reductase Sales by Region: 2021-2026
- 5.2.2 Global Recombinant Carbonyl Reductase Sales by Region: 2027-2032
- 5.3 Global Recombinant Carbonyl Reductase Revenue by Region: 2021-2032
- 5.3.1 Global Recombinant Carbonyl Reductase Revenue by Region: 2021-2026
- 5.3.2 Global Recombinant Carbonyl Reductase Revenue by Region: 2027-2032
- 5.4 North America Recombinant Carbonyl Reductase Market Facts & Figures by Country
- 5.4.1 North America Recombinant Carbonyl Reductase Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Recombinant Carbonyl Reductase Sales by Country (2021-2032)
- 5.4.3 North America Recombinant Carbonyl Reductase Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Recombinant Carbonyl Reductase Market Facts & Figures by Country
- 5.5.1 Europe Recombinant Carbonyl Reductase Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Recombinant Carbonyl Reductase Sales by Country (2021-2032)
- 5.5.3 Europe Recombinant Carbonyl Reductase Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Recombinant Carbonyl Reductase Market Facts & Figures by Country
- 5.6.1 Asia Pacific Recombinant Carbonyl Reductase Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Recombinant Carbonyl Reductase Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Recombinant Carbonyl Reductase Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Recombinant Carbonyl Reductase Market Facts & Figures by Country
- 5.7.1 South America Recombinant Carbonyl Reductase Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Recombinant Carbonyl Reductase Sales by Country (2021-2032)
- 5.7.3 South America Recombinant Carbonyl Reductase Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Recombinant Carbonyl Reductase Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Recombinant Carbonyl Reductase Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Recombinant Carbonyl Reductase Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Recombinant Carbonyl Reductase Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Recombinant Carbonyl Reductase Sales by Type (2021-2032)
- 6.1.1 Global Recombinant Carbonyl Reductase Sales by Type (2021-2032) & (K G)
- 6.1.2 Global Recombinant Carbonyl Reductase Sales Market Share by Type (2021-2032)
- 6.2 Global Recombinant Carbonyl Reductase Revenue by Type (2021-2032)
- 6.2.1 Global Recombinant Carbonyl Reductase Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Recombinant Carbonyl Reductase Revenue Market Share by Type (2021-2032)
- 6.3 Global Recombinant Carbonyl Reductase Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Recombinant Carbonyl Reductase Sales by Application (2021-2032)
- 7.1.1 Global Recombinant Carbonyl Reductase Sales by Application (2021-2032) & (K G)
- 7.1.2 Global Recombinant Carbonyl Reductase Sales Market Share by Application (2021-2032)
- 7.2 Global Recombinant Carbonyl Reductase Revenue by Application (2021-2032)
- 7.2.1 Global Recombinant Carbonyl Reductase Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Recombinant Carbonyl Reductase Revenue Market Share by Application (2021-2032)
- 7.3 Global Recombinant Carbonyl Reductase Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Recombinant Carbonyl Reductase Value Chain Analysis
- 8.1.1 Recombinant Carbonyl Reductase Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Recombinant Carbonyl Reductase Production Mode & Process
- 8.2 Recombinant Carbonyl Reductase Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Recombinant Carbonyl Reductase Distributors
- 8.2.3 Recombinant Carbonyl Reductase Customers
9 Global Recombinant Carbonyl Reductase Analyzing Market Dynamics
- 9.1 Recombinant Carbonyl Reductase Industry Trends
- 9.2 Recombinant Carbonyl Reductase Industry Drivers
- 9.3 Recombinant Carbonyl Reductase Industry Opportunities and Challenges
- 9.4 Recombinant Carbonyl Reductase Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst